USMLE Step 1 Quiz
Practice Diagnostic Test Performance in USMLE Step 1 with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.
Question 1 / 20
0 of 20 answered
A new rapid antigen test for a highly contagious respiratory virus is being evaluated. Researchers want to determine the test's ability to correctly identify patients who truly have the viral infection, as confirmed by PCR testing.
Which of the following test characteristics is being evaluated?
This quiz focuses on Diagnostic Test Performance, giving you a quick way to practice the rules, question types, and explanations that matter most for USMLE Step 1.
Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.
A new rapid antigen test for a highly contagious respiratory virus is being evaluated. Researchers want to determine the test's ability to correctly identify patients who truly have the viral infection, as confirmed by PCR testing.
Which of the following test characteristics is being evaluated?
Explanation: Sensitivity is the ability of a test to correctly identify individuals who have the disease (true positive rate). The question describes assessing the test's performance in a population of known infected individuals.
A pharmaceutical company develops a new biomarker for early-stage pancreatic cancer. A study is designed to assess how well the biomarker test performs in a large group of healthy, asymptomatic individuals by determining the proportion of individuals who correctly test negative.
This study is primarily designed to measure which of the following test characteristics?
Explanation: Specificity is the ability of a test to correctly identify individuals who do not have the disease (true negative rate). The study aims to measure the proportion of healthy individuals who are correctly identified as negative, which is the definition of specificity.
A study evaluates a new ELISA for detecting antibodies to a novel virus. A total of 200 patients with a confirmed viral infection and 300 healthy controls are tested. The ELISA is positive in 180 of the infected patients and positive in 30 of the healthy controls.
What is the sensitivity of this new ELISA for detecting the viral infection?
Explanation: Sensitivity is calculated as True Positives / (True Positives + False Negatives). Here, True Positives (TP) = 180. The total number of infected patients is 200, so False Negatives (FN) = 200 - 180 = 20. Sensitivity = 180 / (180 + 20) = 180 / 200 = 90%.
A new rapid diagnostic test for streptococcal pharyngitis is compared to the gold standard of throat culture. Among 150 patients with a positive throat culture (disease present), the rapid test is positive in 120. Among 250 patients with a negative throat culture (disease absent), the rapid test is negative in 225.
What is the specificity of the rapid diagnostic test?
Explanation: Specificity is calculated as True Negatives / (True Negatives + False Positives). Here, True Negatives (TN) = 225. The total number of patients without the disease is 250, so False Positives (FP) = 250 - 225 = 25. Specificity = 225 / (225 + 25) = 225 / 250 = 90%.
A 45-year-old man with multiple risk factors for coronary artery disease presents with atypical chest pain. The physician wants to perform a test to confidently exclude the presence of significant coronary artery disease. A negative result on this test should provide strong reassurance that the disease is absent.
To achieve this goal, a test with which of the following characteristics would be most useful?
Explanation: A highly sensitive test is best for ruling out a disease. If a test has high sensitivity, it will correctly identify most individuals with the disease, meaning a negative result is very likely to be a true negative. This is often remembered by the mnemonic SN-N-OUT (Sensitive test, Negative result, rules OUT disease).
A screening mammogram for an asymptomatic 50-year-old woman shows a suspicious lesion. Before proceeding with an invasive biopsy, which carries its own risks, the physician wants to perform a follow-up imaging study to confirm that the lesion is likely malignant.
A confirmatory test with which of the following characteristics would be most appropriate in this situation?
Explanation: A highly specific test is best for confirming a diagnosis. If a test has high specificity, it has a low false-positive rate. A positive result from a highly specific test provides strong evidence that the disease is present. This is often remembered by the mnemonic SP-P-IN (Specific test, Positive result, rules IN disease).
A 28-year-old woman with a family history of an autoimmune disorder undergoes a new screening test, and the result is positive. She asks her physician, "Given this positive test result, what is the chance that I actually have this disease?"
The patient's question is asking for which of the following statistical measures?
Explanation: The positive predictive value (PPV) is the probability that a patient with a positive test result truly has the disease. The patient's question directly corresponds to the definition of PPV.
A 65-year-old man undergoes a prostate-specific antigen (PSA) test as part of a routine check-up, and the result is normal. He asks his doctor, "So, what is the probability that I am truly free of prostate cancer, given this normal result?"
The physician will answer the patient's question by providing which of the following values?
Explanation: The negative predictive value (NPV) is the probability that a patient with a negative test result is truly free of the disease. The patient's question directly corresponds to the definition of NPV.
A new blood test for early-stage pancreatic cancer is administered to a high-risk population of 1000 individuals. The prevalence of the disease in this population is 10%. The test has a sensitivity of 80% and a specificity of 90%.
What is the negative predictive value (NPV) of this test in this population?
Explanation: First, construct a 2x2 table. With a prevalence of 10% in a population of 1000, 100 individuals have the disease and 900 do not. False Negatives (FN) = 100 * (1 - sensitivity) = 100 * 0.20 = 20. True Negatives (TN) = 900 * specificity = 900 * 0.90 = 810. NPV = TN / (TN + FN) = 810 / (810 + 20) = 810 / 830 ≈ 98%.
A diagnostic test for Lyme disease has a fixed sensitivity of 95% and specificity of 90%. The test is initially used in a high-risk population of forestry workers where disease prevalence is 20%. The same test is later used as a general screening tool in a low-risk urban population where prevalence is only 1%.
Compared to its use in the high-risk population, what is the most likely effect on the test's positive predictive value (PPV) when used in the low-risk population?
Explanation: The positive predictive value (PPV) is highly dependent on the prevalence of the disease in the population being tested. As the prevalence of a disease decreases, the PPV of a test also decreases. Therefore, using the test in a low-prevalence population will result in a lower PPV.
A new rapid urine test for a specific kidney disease is developed. Its performance is first validated in a tertiary nephrology clinic where 30% of patients have the disease. The test is then implemented in a community primary care setting where the prevalence of the disease is only 2%.
Which of the following test characteristics is expected to remain constant across both the specialty clinic and the primary care setting?
Explanation: Sensitivity and specificity are intrinsic properties of a diagnostic test that do not change with the prevalence of the disease in the population being tested. In contrast, positive and negative predictive values are highly dependent on disease prevalence.
A 25-year-old woman presents with symptoms suggestive of systemic lupus erythematosus (SLE). Her pre-test probability is estimated to be moderate. An anti-dsDNA antibody test is ordered, which has a negative likelihood ratio (LR-) of 0.2 for SLE. The test result comes back negative.
How does this negative test result affect the likelihood of the patient having SLE?
Explanation: The negative likelihood ratio (LR-) indicates how much the odds of disease decrease with a negative test result. An LR- of 0.2 means the post-test odds are 0.2 times the pre-test odds (Post-test odds = Pre-test odds * 0.2). This represents a 1 - 0.2 = 0.8, or an 80% decrease in the odds of having the disease.
A D-dimer test is used to evaluate patients with suspected pulmonary embolism (PE). In a large study, the test was found to have a sensitivity of 95% and a specificity of 50% for PE.
What is the negative likelihood ratio (LR-) of the D-dimer test for PE?
Explanation: The negative likelihood ratio (LR-) is calculated as (1 - sensitivity) / specificity. In this case, LR- = (1 - 0.95) / 0.50 = 0.05 / 0.50 = 0.1. An LR- of 0.1 is considered very useful for ruling out a disease, as a negative result substantially decreases the odds of the disease being present.
Researchers are determining the optimal cut-off value for a new tumor marker to diagnose a specific cancer. They are considering lowering the diagnostic threshold, meaning a lower concentration of the marker will be considered a positive result.
Which of the following would be the most likely consequence of lowering the diagnostic cut-off value?
Explanation: There is an inverse relationship between sensitivity and specificity when a diagnostic cut-off point is changed. Lowering the cut-off value makes it easier to get a positive result. This will correctly identify more individuals with the disease (increasing sensitivity), but it will also incorrectly classify more healthy individuals as positive (increasing false positives, thus decreasing specificity).
A new blood test for early-stage pancreatic cancer is administered to a high-risk population of 1000 individuals. The prevalence of the disease in this population is 10%. The test has a sensitivity of 80% and a specificity of 90%.
What is the positive predictive value (PPV) of this test in this population?
Explanation: First, construct a 2x2 table. With a prevalence of 10% in a population of 1000, 100 individuals have the disease and 900 do not. True Positives (TP) = 100 * sensitivity = 100 * 0.80 = 80. False Positives (FP) = 900 * (1 - specificity) = 900 * 0.10 = 90. PPV = TP / (TP + FP) = 80 / (80 + 90) = 80 / 170 ≈ 47%.
In an emergency department, a physician is evaluating a patient with a high suspicion for a life-threatening condition where a missed diagnosis would be catastrophic. To maximize the chance of detection, two different diagnostic tests are ordered simultaneously. The patient will be considered to have the condition if either Test A or Test B is positive.
What is the main advantage of this parallel testing strategy?
Explanation: This describes parallel testing, where a patient is considered positive if at least one of several tests is positive. This strategy maximizes the probability of detecting the disease, thereby increasing the overall sensitivity of the diagnostic process. The trade-off is a decrease in overall specificity, as there are more opportunities for a false-positive result.
A new serum marker is evaluated for the diagnosis of ovarian cancer. A validation study finds the test has a sensitivity of 75% and a specificity of 95%.
What is the positive likelihood ratio (LR+) for this serum marker?
Explanation: The positive likelihood ratio (LR+) is calculated as sensitivity / (1 - specificity). In this case, LR+ = 0.75 / (1 - 0.95) = 0.75 / 0.05 = 15. This indicates that a positive test result makes it 15 times more likely that the patient has the disease.
An enzyme immunoassay for HIV has a fixed sensitivity of 99.9% and specificity of 99.5%. This test is performed on two different patient groups. Group A consists of individuals from a low-risk community with a disease prevalence of 0.1%. Group B consists of individuals from a high-risk population with a disease prevalence of 15%.
How will the negative predictive value (NPV) of the test in Group A (low prevalence) compare to the NPV in Group B (high prevalence)?
Explanation: The negative predictive value (NPV) is inversely related to the prevalence of the disease in the population. As the prevalence of a disease decreases, the NPV of a test increases. Therefore, the NPV will be higher in the low-prevalence Group A compared to the high-prevalence Group B.
A 55-year-old man presents with chest pain. Based on his history and risk factors, the physician estimates a pre-test probability of coronary artery disease to be 30%. An exercise stress test is performed and is positive. The positive likelihood ratio (LR+) for this test is known to be 5.0.
Which of the following is the most accurate interpretation of this positive test result?
Explanation: The likelihood ratio is a measure of how much a test result changes the odds of having a disease. A positive likelihood ratio (LR+) of 5.0 means that a positive test result makes the odds of having the disease 5 times greater than they were before the test. It is calculated as Post-test odds = Pre-test odds * LR+.
A public health program implements a two-step screening process for a chronic disease. First, an inexpensive and highly sensitive test is administered to a large population. All individuals who test positive are then given a second, more expensive and highly specific test. A person is considered to have the disease only if both tests are positive.
Compared to using the first screening test alone, what is the primary effect of this two-step (serial) testing strategy on the overall diagnostic characteristics?
Explanation: This describes serial testing, where a positive on test 1 is followed by test 2, and the diagnosis is made only if both are positive. This approach increases the overall specificity of the diagnostic process because it reduces the number of false positives that would have occurred with the sensitive screening test alone. However, it decreases the overall sensitivity.